2026 Summer JRM Quiz: #5302

The quiz is derived from the Summer 2026 JRM article, Pancreatic Neuroendocrine and Exocrine Cancer Incidence, and Stage at Diagnosis Before, During, and After the COVID-19 Pandemic, US, 2019-2022 by Suzanne Bock, MPH, S. Jane Henley, MSPH, Mary Elizabeth O’Neil, MPH, Simple D. Singh, MD, MPHm, and Manxia Wu, MD, MPH.

Learning Objectives:

• Describe how pancreatic cancer incidence changed before, during, and after the COVID-19 pandemic.
• Identify patterns in stage at diagnosis for pancreatic neuroendocrine and exocrine  cancers during the COVID-19 period.
• Understand how disruptions in healthcare access during COVID-19 affected cancer diagnosis trends.

Credit Information

Activity Number	Credit Amount	Accreditation Period
2026-197	1 CE	July 15, 2026 - July 15, 2028